Select Publications

Journal articles

Nazareno AL; Newall AT; Muscatello DJ; Hogan AB; Wood JG, 2024, 'Modelling the epidemiological impact of maternal respiratory syncytial virus (RSV) vaccination in Australia', Vaccine, 42, http://dx.doi.org/10.1016/j.vaccine.2024.126418

Gebremedhin AT; Hogan AB; Blyth CC; Glass K; Moore HC, 2024, 'Author Correction: Developing a prediction model to estimate the true burden of respiratory syncytial virus (RSV) in hospitalised children in Western Australia (Scientific Reports, (2022), 12, 1, (332), 10.1038/s41598-021-04080-3)', Scientific Reports, 14, http://dx.doi.org/10.1038/s41598-024-52791-0

Giannini F; Hogan AB; Sarna M; Glass K; Moore HC, 2024, 'Modelling respiratory syncytial virus age-specific risk of hospitalisation in term and preterm infants', BMC Infectious Diseases, 24, http://dx.doi.org/10.1186/s12879-024-09400-2

Le T; Abell I; Conway E; Campbell PT; Hogan AB; Lydeamore MJ; McVernon J; Mueller I; Walker CR; Baker CM, 2024, 'Modelling the impact of hybrid immunity on future COVID-19 epidemic waves', BMC Infectious Diseases, 24, http://dx.doi.org/10.1186/s12879-024-09282-4

Barnsley G; Olivera Mesa D; Hogan AB; Winskill P; Torkelson AA; Walker DG; Ghani AC; Watson OJ, 2024, 'Impact of the 100 days mission for vaccines on COVID-19: a mathematical modelling study', The Lancet Global Health, 12, pp. e1764 - e1774, http://dx.doi.org/10.1016/S2214-109X(24)00286-9

Lambach P; Silal S; Sbarra AN; Koh M; Aggarwal R; Farooqui HH; Flasche S; Hogan AB; Kim SY; Leung K; Moss WJ; Munywoki PK; Portnoy A; Sheel M; Wang XY, 2024, 'Corrigendum to “Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) meeting, virtual gathering, 26 February–1 March 2024” [Vaccine 42(15) (2024) 3379–3383, (S0264410X24004948), (10.1016/j.vaccine.2024.04.057)]', Vaccine, 42, http://dx.doi.org/10.1016/j.vaccine.2024.07.003

Watson OJ; Hogan AB, 2024, 'Impact of COVID-19 vaccination programmes in Europe: lives saved and lessons learned', The Lancet Respiratory Medicine, 12, pp. 663 - 664, http://dx.doi.org/10.1016/S2213-2600(24)00214-5

Lambach P; Silal S; Sbarra AN; Koh M; Aggarwal R; Farooqui HH; Flasche S; Hogan AB; Kim SY; Leung K; Moss WJ; Munywoki PK; Portnoy A; Sheel M; Wang XY, 2024, 'Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) meeting, virtual gathering, 26 February–1 March 2024', Vaccine, 42, pp. 3379 - 3383, http://dx.doi.org/10.1016/j.vaccine.2024.04.057

Lambach P; Orenstein W; Silal S; Sbarra AN; Koh M; Aggarwal R; Hasan Farooqui H; Flasche S; Hogan A; Kim SY; Leask J; Luz PM; Lyimo DC; Moss WJ; Pitzer VE; Wang XY; Wu J, 2024, 'Report from the World Health Organization's immunization and vaccines related implementation research advisory committee (IVIR-AC) meeting, Geneva, 11–13 September 2023', Vaccine, 42, pp. 1424 - 1434, http://dx.doi.org/10.1016/j.vaccine.2024.02.014

Hogan A, 2024, 'Baby in tow', Science, 383, pp. 562, http://dx.doi.org/10.1126/science.ado3078

Hogan AB; Doohan P; Wu SL; Mesa DO; Toor J; Watson OJ; Winskill P; Charles G; Barnsley G; Riley EM; Khoury DS; Ferguson NM; Ghani AC, 2023, 'Estimating long-term vaccine effectiveness against SARS-CoV-2 variants: a model-based approach', Nature Communications, 14, pp. 4325, http://dx.doi.org/10.1038/s41467-023-39736-3

Bents SJ; Viboud C; Grenfell BT; Hogan AB; Tempia S; von Gottberg A; Moyes J; Walaza S; Hansen C; Cohen C; Baker RE, 2023, 'Modeling the impact of COVID-19 nonpharmaceutical interventions on respiratory syncytial virus transmission in South Africa', Influenza and other Respiratory Viruses, 17, pp. e13229, http://dx.doi.org/10.1111/irv.13229

Hogan AB; Wu SL; Toor J; Mesa DO; Doohan P; Watson OJ; Winskill P; Charles G; Barnsley G; Riley EM; Khoury DS; Ferguson NM; Ghani AC, 2023, 'Long-term vaccination strategies to mitigate the impact of SARS-CoV-2 transmission: A modelling study', PLoS Medicine, 20, pp. e1004195, http://dx.doi.org/10.1371/journal.pmed.1004195

Imai N; Rawson T; Knock ES; Sonabend R; Elmaci Y; Perez-Guzman PN; Whittles LK; Kanapram DT; Gaythorpe KAM; Hinsley W; Djaafara BA; Wang H; Fraser K; FitzJohn RG; Hogan AB; Doohan P; Ghani AC; Ferguson NM; Baguelin M; Cori A, 2023, 'Quantifying the effect of delaying the second COVID-19 vaccine dose in England: a mathematical modelling study', The Lancet Public Health, 8, pp. e174 - e183, http://dx.doi.org/10.1016/S2468-2667(22)00337-1

Gebremedhin AT; Hogan AB; Blyth CC; Glass K; Moore HC, 2022, 'Developing a prediction model to estimate the true burden of respiratory syncytial virus (RSV) in hospitalised children in Western Australia', Scientific Reports, 12, http://dx.doi.org/10.1038/s41598-021-04080-3

Olivera Mesa D; Hogan AB; Watson OJ; Charles GD; Hauck K; Ghani AC; Winskill P, 2022, 'Modelling the impact of vaccine hesitancy in prolonging the need for Non-Pharmaceutical Interventions to control the COVID-19 pandemic', Communications Medicine, 2, http://dx.doi.org/10.1038/s43856-022-00075-x

Thompson HA; Hogan AB; Walker PGT; Winskill P; Zongo I; Sagara I; Tinto H; Ouedraogo JB; Dicko A; Chandramohan D; Greenwood B; Cairns M; Ghani AC, 2022, 'Seasonal use case for the RTS,S/AS01 malaria vaccine: a mathematical modelling study', The Lancet Global Health, 10, pp. e1782 - e1792, http://dx.doi.org/10.1016/S2214-109X(22)00416-8

Watson OJ; Barnsley G; Toor J; Hogan AB; Winskill P; Ghani AC, 2022, 'Global impact of the first year of COVID-19 vaccination: a mathematical modelling study', The Lancet Infectious Diseases, 22, pp. 1293 - 1302, http://dx.doi.org/10.1016/S1473-3099(22)00320-6

Haw DJ; Forchini G; Doohan P; Christen P; Pianella M; Johnson R; Bajaj S; Hogan AB; Winskill P; Miraldo M; White PJ; Ghani AC; Ferguson NM; Smith PC; Hauck KD, 2022, 'Optimizing social and economic activity while containing SARS-CoV-2 transmission using DAEDALUS', Nature Computational Science, 2, pp. 223 - 233, http://dx.doi.org/10.1038/s43588-022-00233-0

Unwin HJT; Mwandigha L; Winskill P; Ghani AC; Hogan AB, 2021, 'Analysis of the potential for a malaria vaccine to reduce gaps in malaria intervention coverage', Malaria Journal, 20, http://dx.doi.org/10.1186/s12936-021-03966-x

Winskill P; Hogan AB; Thwing J; Mwandigha L; Walker PGT; Lambert B, 2021, 'Health inequities and clustering of fever, acute respiratory infection, diarrhoea and wasting in children under five in low- and middle-income countries: a Demographic and Health Surveys analysis', BMC Medicine, 19, http://dx.doi.org/10.1186/s12916-021-02018-0

Skarp JE; Downey LE; Ohrnberger JWE; Cilloni L; Hogan AB; Sykes AL; Wang SS; Shah HA; Xiao M; Hauck K, 2021, 'A Systematic Review of the Costs Relating to Non-pharmaceutical Interventions Against Infectious Disease Outbreaks', Applied Health Economics and Health Policy, 19, pp. 673 - 697, http://dx.doi.org/10.1007/s40258-021-00659-z

Prasad N; Read JM; Jewell C; Waite B; Trenholme AA; Huang QS; Grant CC; Newbern EC; Hogan AB, 2021, 'Modelling the impact of respiratory syncytial virus (RSV) vaccine and immunoprophylaxis strategies in New Zealand', Vaccine, 39, pp. 4383 - 4390, http://dx.doi.org/10.1016/j.vaccine.2021.05.100

Hogan AB; Winskill P; Watson OJ; Walker PGT; Whittaker C; Baguelin M; Brazeau NF; Charles GD; Gaythorpe KAM; Hamlet A; Knock E; Laydon DJ; Lees JA; Løchen A; Verity R; Whittles LK; Muhib F; Hauck K; Ferguson NM; Ghani AC, 2021, 'Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: A mathematical modelling analysis', Vaccine, 39, pp. 2995 - 3006, http://dx.doi.org/10.1016/j.vaccine.2021.04.002

Imai N; Hogan A; Williams L; Cori A; Mangal T; Winskill P; Whittles L; Watson O; Knock E; Baguelin M; Perez-Guzman P; Gaythorpe KAM; Sonabend R; Ghani A; Ferguson N, 2021, 'Interpreting estimates of coronavirus disease 2019 (COVID-19) vaccine efficacy and effectiveness to inform simulation studies of vaccine impact: a systematic review', , http://dx.doi.org/10.12688/wellcomeopenres.16992.1

Campbell PT; Geard N; Hogan AB, 2020, 'Modelling the household-level impact of a maternal respiratory syncytial virus (RSV) vaccine in a high-income setting', BMC Medicine, 18, http://dx.doi.org/10.1186/s12916-020-01783-8

Hogan AB; Winskill P; Ghani AC, 2020, 'Estimated impact of RTS,S/AS01 malaria vaccine allocation strategies in sub-Saharan Africa: A modelling study', PLoS Medicine, 17, http://dx.doi.org/10.1371/JOURNAL.PMED.1003377

Thompson HA; Hogan AB; Walker PGT; White MT; Cunnington AJ; Ockenhouse CF; Ghani AC, 2020, 'Modelling the roles of antibody titre and avidity in protection from Plasmodium falciparum malaria infection following RTS,S/AS01 vaccination', Vaccine, 38, pp. 7498 - 7507, http://dx.doi.org/10.1016/j.vaccine.2020.09.069

Hogan AB; Jewell BL; Sherrard-Smith E; Vesga JF; Watson OJ; Whittaker C; Hamlet A; Smith JA; Winskill P; Verity R; Baguelin M; Lees JA; Whittles LK; Ainslie KEC; Bhatt S; Boonyasiri A; Brazeau NF; Cattarino L; Cooper LV; Coupland H; Cuomo-Dannenburg G; Dighe A; Djaafara BA; Donnelly CA; Eaton JW; van Elsland SL; FitzJohn RG; Fu H; Gaythorpe KAM; Green W; Haw DJ; Hayes S; Hinsley W; Imai N; Laydon DJ; Mangal TD; Mellan TA; Mishra S; Nedjati-Gilani G; Parag KV; Thompson HA; Unwin HJT; Vollmer MAC; Walters CE; Wang H; Wang Y; Xi X; Ferguson NM; Okell LC; Churcher TS; Arinaminpathy N; Ghani AC; Walker PGT; Hallett TB, 2020, 'Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study', The Lancet Global Health, 8, pp. e1132 - e1141, http://dx.doi.org/10.1016/S2214-109X(20)30288-6

Sherrard-Smith E; Hogan AB; Hamlet A; Watson OJ; Whittaker C; Winskill P; Ali F; Mohammad AB; Uhomoibhi P; Maikore I; Ogbulafor N; Nikau J; Kont MD; Challenger JD; Verity R; Lambert B; Cairns M; Rao B; Baguelin M; Whittles LK; Lees JA; Bhatia S; Knock ES; Okell L; Slater HC; Ghani AC; Walker PGT; Okoko OO; Churcher TS, 2020, 'The potential public health consequences of COVID-19 on malaria in Africa', Nature Medicine, 26, pp. 1411 - 1416, http://dx.doi.org/10.1038/s41591-020-1025-y

Hogan AB; Winskill P; Verity R; Griffin JT; Ghani AC, 2018, 'Modelling population-level impact to inform target product profiles for childhood malaria vaccines', BMC Medicine, 16, http://dx.doi.org/10.1186/s12916-018-1095-6

Hogan AB; Campbell PT; Blyth CC; Lim FJ; Fathima P; Davis S; Moore HC; Glass K, 2017, 'Potential impact of a maternal vaccine for RSV: A mathematical modelling study', Vaccine, 35, pp. 6172 - 6179, http://dx.doi.org/10.1016/j.vaccine.2017.09.043

Hogan AB; Glass K; Anderssen RS, 2017, 'Complex demodulation: a novel time series method for analysing seasonal infectious diseases', ANZIAM Journal, 59, pp. 51 - 51, http://dx.doi.org/10.21914/anziamj.v59i0.10894

Hogan AB; Glass K; Anderssen RS, 2017, 'COMPLEX DEMODULATION: A NOVEL TIME SERIES METHOD for ANALYSING SEASONAL INFECTIOUS DISEASES', ANZIAM Journal, 59, pp. 51 - 60, http://dx.doi.org/10.1017/S1446181116000377

Hogan AB; Myerscough MR, 2017, 'A Model for the Spread of an Invasive Weed, Tradescantia fluminensis', Bulletin of Mathematical Biology, 79, pp. 1201 - 1217, http://dx.doi.org/10.1007/s11538-017-0280-7

Smith RJ; Hogan AB; Mercer GN, 2017, 'Unexpected infection spikes in a model of respiratory syncytial virus vaccination', Vaccines, 5, http://dx.doi.org/10.3390/vaccines5020012

Hogan AB; Anderssen RS; Davis S; Moore HC; Lim FJ; Fathima P; Glass K, 2016, 'Time series analysis of RSV and bronchiolitis seasonality in temperate and tropical Western Australia', Epidemics, 16, pp. 49 - 55, http://dx.doi.org/10.1016/j.epidem.2016.05.001

Hogan AB; Glass K; Moore HC; Anderssen RS, 2016, 'Exploring the dynamics of respiratory syncytial virus (RSV) transmission in children', Theoretical Population Biology, 110, pp. 78 - 85, http://dx.doi.org/10.1016/j.tpb.2016.04.003

Moore HC; Jacoby P; Hogan AB; Blyth CC; Mercer GN, 2014, 'Modelling the seasonal epidemics of respiratory syncytial virus in young children', PLoS ONE, 9, http://dx.doi.org/10.1371/journal.pone.0100422


Back to profile page